Bavencio and ReVia

• Generic Name: avelumab
• Dosage Forms: injection, solution, concentrate
• Other Brand Names: Bavencio

Bavencio (avelumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Bavencio is used to treat a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children at least 12 years old, when the cancer has spread to other parts of the body (metastatic).

Bavencio was approved for MCC by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, tumors responded to this medicine. However, further studies are needed.

Bavencio is used to treat a certain type of cancer of the bladder or urinary tract that has spread or cannot be removed with surgery. Avelumab is given for this condition after platinum cancer medicines did not work or have stopped working.

Bavencio is also used used alone or in combination with the medicine axitinib for the treatment of a type of kidney cancer called renal cell carcinoma (RCC) that has spread or cannot be removed by surgery (advanced RCC).

• Generic Name: naltrexone
• Dosage Forms: tablet, film coated
• Other Brand Names: ReVia, Depade, Vivitrol

ReVia blocks the effects of opioid medication, including pain relief or feelings of well-being that can lead to opioid abuse. An opioid is sometimes called a narcotic. This medicine is used as part of a treatment program for drug or alcohol dependence.

ReVia is used to prevent relapse in people who became dependent on opioid medicine and then stopped using it. This medicine can help keep you from feeling a "need" to use the opioid.

ReVia is also used to treat alcoholism by reducing your urge to drink alcohol. This may help you drink less or stop drinking completely. This medicine will not cause you to "sober up" and will not decrease the effects of alcohol you recently consumed.

ReVia is not a cure for drug addiction or alcoholism.

ReVia may also be used for purposes not listed in this medication guide.